Rare diseases
Investigational molecules
Locations
Back to Germany434 clinical trials in Kiel, Germany across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study of Cytarabine and Daunorubicin for Treating Myeloid Leukemia in Children with Down Syndrome
GermanyORKA-001 in Patients with Moderate-to-Severe Plaque Psoriasis
GermanyA study to evaluate the safety and effectiveness of galvokimig in adults with moderate to severe atopic dermatitis
GermanyA Study of KT-621 Tablets Taken by Mouth for Adults with Moderate to Severe Atopic Dermatitis
GermanyStudy of IPN10200 compared to placebo for prevention of episodic or chronic migraine in adults
GermanyStudy of zasocitinib (TAK-279) and apremilast compared to placebo in adults with moderate to severe plaque psoriasis
GermanyStudy of Rocatinlimab Treatment for Adults and Adolescents with Moderate to Severe Atopic Dermatitis
GermanyLong-term safety and effectiveness study of sonelokimab injections for patients with moderate to severe hidradenitis suppurativa
GermanyStudy of AZD0780 in patients with high cholesterol and heart disease or risk of heart disease to lower bad cholesterol levels
GermanyStudy of Ruxolitinib Cream for Children and Adolescents Ages 6-17 with Moderate Atopic Dermatitis Who Did Not Respond Well to Standard Treatments
GermanyStudy on LY3848575 for Reducing Pain in Patients with Distal Sensory Polyneuropathy
GermanyStudy on the Effectiveness and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab for Patients with Moderate to Severe Plaque Psoriasis
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on breast cancer treatments, including studies of ribociclib with endocrine therapy for HR-positive, HER2-negative cases. Additional research encompasses various blood cancers, including lymphomas and leukemia.
Cutting-edge research evaluating novel therapeutic combinations and treatment approaches for better patient outcomes.
Comprehensive research into chronic skin conditions, including trials for plaque psoriasis and atopic dermatitis. Studies evaluate new therapeutic agents for moderate to severe cases.
Focus on developing effective treatments for persistent skin conditions that significantly impact quality of life.
Advanced studies in inflammatory bowel diseases, particularly Crohn's disease and ulcerative colitis. Trials investigate innovative therapies for moderate to severe cases.
Investigation of new therapeutic options for patients with inadequate response to conventional treatments.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
